rss
Br J Ophthalmol 2005;89:871-873 doi:10.1136/bjo.2004.056580
  • Clinical science
    • Extended reports

Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay

  1. H Yokota1,
  2. F Mori1,
  3. K Kai1,
  4. T Nagaoka1,
  5. N Izumi1,
  6. A Takahashi1,
  7. T Hikichi1,
  8. A Yoshida1,
  9. F Suzuki2,
  10. Y Ishida3
  1. 1Department of Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  2. 2Faculty of Applied Biological Science, Gifu University, Gifu, Japan
  3. 3Preveqol Co, Tokyo, Japan
  1. Correspondence to: Harumasa Yokota MD, Department of Ophthalmology, Asahikawa Medical College, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510 Japan; atokoy18asahikawa-med.ac.jp
  • Accepted 1 December 2004

Abstract

Aim: To investigate the serum levels of prorenin and its correlation with the severity of diabetic retinopathy (DR).

Methods: 248 patients with diabetes and 108 control subjects were divided into four groups: no-DR (n = 146), no proliferative diabetic retinopathy (no-PDR) (n = 78), PDR (n = 24), and controls (n = 108). Serum levels of prorenin from all subjects were measured using the new antibody activating direct kinetic (AAD-PR) assay. The serum prorenin levels were compared among the groups.

Results: The serum levels of prorenin in the control, no-DR, no-PDR, and PDR groups, respectively, were 109.1 (66.1), 194.6 (160.4), 271.5 (220.3), and 428.4 (358.4) pg/ml (mean (SD)). Prorenin in the PDR group was remarkably high compared with the control and no-DR groups (p<0.0001) and with the no-PDR group (p = 0.002). Serum levels of prorenin increased with increasingly severe retinopathy. No correlation was found between the prorenin level and the duration of disease or HbA1c.

Conclusions: The serum levels of prorenin in patients with PDR were found to be markedly high using the AAD-PR assay. Increased levels of prorenin in diabetes may have an important role in the pathogenesis of DR.

Footnotes

  • The authors have no proprietary interest in any aspect of this report.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.